Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hypertension 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Non-alcoholic Fatty Liver Disease 1Lymphoma, Follicular 1Lymphoma 1Hematologic Neoplasms 1Dyspnea 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

relacorilant 5Nutrition Assessment 4Hydrochlorothiazide 3Amlodipine 3aliskiren 2Osilodrostat 2Lisinopril 2Bevacizumab 2Adrenalectomy 2sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1pazopanib 1lutetium Lu 177 dotatate 1ganirelix 1gallium Ga 68 dotatate 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1benazepril 1Vitamin D 1Tumor Necrosis Factors 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sulindac 1Sodium Chloride 1Resistance Training 1Receptors, Androgen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hypertension × Lisinopril × Clear all
NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Wake Forest University Health Sciences

Phase 2 Terminated
6 enrolled 10 charts

Hypertension

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed
2 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡